The Duke EMPOWER study team partnered with Pattern to help patients with Interstitial Lung Disease discover relevant clinical trials, access information and exercise plans, track biometrics, and more!
FDA Embraces Decentralized Clinical Trials (DCT): What You Need to Know
The U.S. Food and Drug Administration (FDA) recently released its long-awaited draft guidance supporting the use of decentralized clinical trials (DCTs) for drugs, biologics, and devices. The new guidance clarifies the FDA's position on DCTs, inspiring confidence in their use...
Heart Failure CONNECT-HF Study Used Pattern Health App to Study Medication Adherence, Quality-of-Care Scores
The Duke Clinical Research Institute study was the first to incorporate mobile health technology to follow heart failure patients long-term. The study showed that using patients’ biometric information and medication adherence data can help customize guideline-based recommendations to improve self-care....
Demystifying Digital Health Research Jargon
When working with researchers and clinicians to design trials that include digital elements, it's important to speak the same language. Just as clinical lingo must be precise so that everyone understands its meaning, adding digital elements to a clinical trial...
Pattern Adds Withings Integration to Expand Real-World Data (RWD) Collection Options
Pattern’s digital health platform now offers out-of-the-box integration with Withings’ Health Mate app. This integration makes it easier than ever for researchers to include fan-favorite biometric devices in their research studies such as the ScanWatch (hybrid smartwatch with ECG, heartrate,...
Study Incentives Drawing the Wrong Crowd?
How to incentivize study participation while avoiding fraud. It's a Catch-22. Research studies often pay participants for their time and involvement, but that payment can be a magnet, attracting people who don't actually qualify. Without the proper controls in place,...
Academic Medical Centers: The Increasing Importance of Translational Research
The phrase “translational research” often refers to pharmaceutical companies moving from basic clinical research into drug development. Sometimes pharma companies do this research themselves, and sometimes they license compounds from Academic Medical Centers (AMCs), with technology transfer deals bringing revenue...
